These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19197558)

  • 1. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
    Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
    Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
    Taverna JA; Lerner A; Bhawan J; Demierre MF
    J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y; Foshee JB; Sontheimer RD
    J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab for patients with refractory mucous membrane pemphigoid.
    Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
    Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of mucous membrane pemphigoid with infliximab.
    Heffernan MP; Bentley DD
    Arch Dermatol; 2006 Oct; 142(10):1268-70. PubMed ID: 17043180
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in the treatment of autoimmune haematological disorders.
    Provan D; Newland AC; Amadori S; Stasi R
    Br J Haematol; 2008 Oct; 143(2):294; author reply 295. PubMed ID: 18752592
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
    Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
    Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
    Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
    Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
    [No Abstract]   [Full Text] [Related]  

  • 12. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
    Flores-Climente V; Rozas-Muñoz E; Martínez-Grau A; Aucouturier F; Luna S; Baselga E
    Pediatr Dermatol; 2019 Nov; 36(6):984-985. PubMed ID: 31448438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of mucous membrane pemphigoid. Results of the 1st International Consensus Conference].
    Hautarzt; 2002 May; 53(5):371-2. PubMed ID: 12063752
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
    Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rituximab use in mucous membrane pemphigoid].
    Bertrand AS; Dereure O; Girard C; Bessis D; Guillot B
    Ann Dermatol Venereol; 2019 Oct; 146(10):659-661. PubMed ID: 31358309
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.
    Witte M; Zillikens D; Shimanovich I
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
    Galdos M; Etxebarría J
    Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.
    Huff SB; Vasu S; Kaffenberger BH
    Int J Dermatol; 2019 Feb; 58(2):240-241. PubMed ID: 29707776
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Bernard P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):259-63. PubMed ID: 21397156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.